Tag: Wegovy
-
Postpartum GLP-1 Drugs See Sharp Rise, Danish Study Finds
Overview: A Surprising Postpartum Trend A recent Danish study reveals a notable uptick in the prescription of GLP-1 drugs—widely known for aiding weight loss and blood sugar control—among women in the period following childbirth. Researchers were initially examining medication use during and after pregnancy, but the data soon highlighted a clear trend: more women are…
-
Overcoming Nausea: The Next Wave of Weight-Loss Drugs and Safer Experiences
Search for a ‘painless’ path to weight loss Millions of Americans have found success with prescription medications like Wegovy and Zepbound, which help reduce appetite and boost weight loss. Yet the journey isn’t the same for everyone. A common obstacle is nausea, a side effect that can range from mild discomfort to significant disruption in…
-
Brain scientists pursue nausea-free weight-loss drugs amid GLP-1 breakthroughs
Overview: The quest for nausea-free weight-loss medications Millions of Americans have achieved impressive weight loss with medications such as Wegovy and Zepbound, which target the body’s GLP-1 pathways to curb appetite and boost metabolic effects. Yet the journey with these drugs isn’t without rough edges. Nausea, vomiting, and other gastrointestinal side effects remain common early…
-
Brain scientists pursue nausea-free weight-loss drugs to improve outcomes
Overview: The quest for nausea-free weight-loss drugs Across the United States and beyond, millions have found success shedding pounds with medications such as Wegovy and Zepbound. These GLP-1 receptor agonists help reduce appetite and slow digestion, leading to meaningful weight loss for many individuals. Yet the journey isn’t without its rough edges. A sizable share…
-
Could Ozempic and Wegovy Cut Cancer Death Risk? Emerging Study Sparks Hope and Caution
New findings spark hope for GLP-1 drugs Recent research points to a surprising potential benefit of GLP-1 receptor agonists — the same class that includes weight‑loss medications Ozempic and Wegovy. A growing body of observational data suggests these drugs may be associated with improved cancer survival, particularly in colon cancer. While the results are intriguing,…
-
Could Ozempic and Wegovy Cut Colon Cancer Mortality? New Study Sparks Hope
Surprising findings from a new study In recent months, researchers have turned their attention to whether GLP-1 receptor agonists—drugs best known for aiding weight loss—might also influence cancer outcomes. Ozempic (semaglutide) and Wegovy (semaglutide for chronic weight management) belong to this class. A fresh analysis indicates that users of these medications could experience a meaningful…
-
GLP-1 Drugs Ozempic Wegovy May Cut Cancer Death Risk in Obese Patients
New findings spark debate about GLP-1 drugs and cancer outcomes A recent study exploring the impact of GLP-1 receptor agonists, including popular weight loss drugs Ozempic and Wegovy, has drawn attention for potential improvements in cancer survival. While the research is early and observational in nature, it suggests that patients using these medications may experience…
-
Trump Admin Secures Deals to Lower GLP-1 Weight-Loss Drug Prices for Medicare and Private Patients
Overview: Aiming to curb rising costs for GLP-1 medications The Trump administration announced a landmark set of deals on Thursday with the pharmaceutical giants Novo Nordisk and Eli Lilly. The agreements are designed to reduce the out-of-pocket and list prices of GLP-1 drugs—medications increasingly prescribed for weight management and diabetes—especially for Medicare beneficiaries and other…
-
Unusual PET-CT Scan Patterns Linked to GLP-1 Weight-Loss Drugs
Overview: A new imaging wrinkle around popular GLP-1 medications GLP-1 receptor agonists, a class of drugs that has surged in popularity for weight loss and type 2 diabetes management, are facing fresh scrutiny. While these medications—sold under names like Ozempic, Wegovy, and Mounjaro—continue to help many shed pounds, doctors are now noting unfamiliar patterns on…
-
Unusual GLP-1 Drug Side Effect Could Skew PET-CT Scans, Study Warns
GLP-1 drugs are reshaping weight loss—and now imaging, too GLP-1 receptor agonists, best known by brand names like Ozempic, Wegovy, and Mounjaro, have surged in popularity for their powerful weight‑loss effects. But as their use has exploded—driven by a 700% rise in the United States from 2019 to 2023—so too have reports of unusual side…